Sutro Biopharma, Inc. (FRA:S090)
Germany · Delayed Price · Currency is EUR 12.50
-0.50 (-3.85%)
At close: Jan 23, 2026
Sutro Biopharma Revenue
Sutro Biopharma had revenue of $9.69M USD in the quarter ending September 30, 2025, with 13.77% growth. This brings the company's revenue in the last twelve months to $105.65M, down -34.36% year-over-year. In the year 2024, Sutro Biopharma had annual revenue of $62.04M, down -59.64%.
Revenue (ttm)
$105.65M
Revenue Growth
-34.36%
P/S Ratio
1.19
Revenue / Employee
$593.52K
Employees
178
Market Cap
107.20M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.04M | -91.69M | -59.64% |
| Dec 31, 2023 | 153.73M | 85.96M | 126.84% |
| Dec 31, 2022 | 67.77M | 5.89M | 9.52% |
| Dec 31, 2021 | 61.88M | 19.16M | 44.84% |
| Dec 31, 2020 | 42.72M | -14.00K | -0.03% |
| Dec 31, 2019 | 42.74M | 4.32M | 11.24% |
| Dec 31, 2018 | 38.42M | -13.32M | -25.75% |
| Dec 31, 2017 | 51.74M | -7.99M | -13.38% |
| Dec 31, 2016 | 59.73M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Netfonds AG | 239.33M |
| Mineralbrunnen Überkingen-Teinach GmbH & Co. KGaA | 160.33M |
| Meta Wolf AG | 122.26M |
| LEWAG Holding Aktiengesellschaft | 112.27M |
| CeoTronics AG | 68.83M |
| Sparta AG | 65.19M |
| ParTec AG | 48.67M |
| AGROB Immobilien AG | 12.72M |